Michael Morrissey

Director Ejecutivo en EXELIXIS, INC. .

Fortuna: 90 M $ al 31/12/2024

64 años

Health Technology

Consumer Services

Noticias sobre Michael Morrissey

Exelixis, Inc. Presents at 43rd Annual J.P. Morgan Healthcare Conference 2025, Jan-13-2025 05:15 PM	14/01
Exelixis, Inc. Presents at Guggenheim Securities Inaugural Healthcare Innovation Conference, Nov-12-2024 09:00 AM	12/11
Exelixis, Inc., Q3 2024 Earnings Call, Oct 29, 2024	29/10/24
Exelixis, Inc., Q2 2024 Earnings Call, Aug 06, 2024	06/08/24
Exelixis, Inc., Q1 2024 Earnings Call, Apr 30, 2024	30/04/24
Exelixis, Inc. Presents at Guggenheim Healthcare Talks\| 6th Annual Biotechnology Conference, Feb-08-2024 09:00 AM	08/02/24
Exelixis, Inc., Q4 2023 Earnings Call, Feb 06, 2024	06/02/24
Exelixis, Inc. Presents at J.P. Morgan 42nd Annual Healthcare Conference 2024, Jan-08-2024 04:30 PM	09/01/24
Exelixis, Inc. - Special Call	12/12/23
Exelixis, Inc., Q3 2023 Earnings Call, Nov 01, 2023	01/11/23
Exelixis, Inc., Q2 2023 Earnings Call, Aug 01, 2023	01/08/23
Exelixis, Inc. Presents at Goldman Sachs 44th Annual Global Healthcare Conference, Jun-13-2023 04:00 PM	14/06/23
Exelixis, Inc., Q1 2023 Earnings Call, May 09, 2023	09/05/23
Exelixis, Inc. Presents at Oppenheimer 33rd Annual Healthcare Conference, Mar-14-2023 01:20 PM	14/03/23
Exelixis, Inc., Q4 2022 Earnings Call, Feb 07, 2023	07/02/23
Exelixis, Inc. Presents at 41st Annual J.P. Morgan Healthcare Conference, Jan-09-2023 05:15 PM	10/01/23
Exelixis, Inc., Q3 2022 Earnings Call, Nov 01, 2022	01/11/22
Exelixis, Inc., Q2 2022 Earnings Call, Aug 09, 2022	09/08/22
Exelixis, Inc., Q1 2022 Earnings Call, May 10, 2022	10/05/22
Vera Therapeutics anuncia el nombramiento del doctor Michael M. Morrissey como presidente de su consejo de administración	12/04/22	CI
Exelixis, Inc. Presents at Oppenheimer's 32nd Annual Healthcare Conference, Mar-15-2022 02:00 PM	15/03/22
Exelixis, Inc., Q4 2021 Earnings Call, Feb 17, 2022	17/02/22
Exelixis, Inc. Presents at 4th Annual Guggenheim Oncology Day, Feb-09-2022 01:30 PM	09/02/22
Exelixis, Inc. Presents at JPMorgan 40th Annual Healthcare Conference, Jan-10-2022 05:15 PM	10/01/22
Exelixis, Inc. Presents at BMO Biopharma Spotlight Series: Emerging Trends & Therapeutics in Oncology, Nov-08-2021 12:10 PM	08/11/21
Exelixis, Inc., Q3 2021 Earnings Call, Nov 02, 2021	02/11/21
Exelixis, Inc. Presents at Cantor Global Healthcare 2021 Conference, Sep-29-2021 02:40 PM	29/09/21
Exelixis, Inc. Presents at H.C. Wainwright 23rd Annual Global Investment Conference, Sep-13-2021 07:00 AM	13/09/21
Exelixis, Inc., Q2 2021 Earnings Call, Aug 05, 2021	05/08/21
Exelixis alcanza uno de los dos criterios de valoración coprimarios en el estudio de última fase de un fármaco combinado contra el cáncer de hígado	28/06/21	MT
Exelixis, Inc. Presents at Goldman Sachs 42nd Annual Global Healthcare Conference, Jun-09-2021 01:20 PM	09/06/21
Exelixis, Inc. - Shareholder/Analyst Call	26/05/21
Exelixis, Inc., Q1 2021 Earnings Call, May 06, 2021	06/05/21
Exelixis, Inc. Presents at Oppenheimer 31st Annual Healthcare Conference, Mar-16-2021 11:20 AM	16/03/21
Exelixis, Inc. Presents at SVB Leerink 10th Annual Global Healthcare Conference 2021, Feb-26-2021 01:00 PM	26/02/21
Exelixis, Inc. Presents at Guggenheim Healthcare Talks 2021 Oncology Day, Feb-11-2021 11:30 AM	11/02/21
Exelixis, Inc., Q4 2020 Earnings Call, Feb 10, 2021	10/02/21
Exelixis, Inc. Presents at Evercore ISI 3rd Annual HealthCONx Conference, Dec-01-2020 03:05 PM	01/12/20
Exelixis, Inc. Presents at 2020 Stifel Virtual Healthcare Conference, Nov-18-2020 02:00 PM	18/11/20
Exelixis, Inc. Presents at 29th Annual Virtual Healthcare Conference, Nov-10-2020 04:15 PM	10/11/20
Exelixis, Inc., Q3 2020 Earnings Call, Nov 05, 2020	05/11/20
Exelixis, Inc. Presents at Cantor’s 2020 Global Healthcare Conference, Sep-16-2020 04:40 PM	16/09/20
Exelixis, Inc., Q2 2020 Earnings Call, Aug 06, 2020	06/08/20
Exelixis, Inc. - Shareholder/Analyst Call	20/05/20
Exelixis, Inc. Presents at UBS Virtual Global Healthcare Conference, May-19-2020 04:40 PM	19/05/20
Exelixis, Inc., Q1 2020 Earnings Call, May 05, 2020	05/05/20
Exelixis, Inc., Q4 2019 Earnings Call, Feb 25, 2020	25/02/20
Exelixis, Inc. Presents at Guggenheim Healthcare Talks Idea Forum Oncology Day 2020, Feb-13-2020 09:00 AM	13/02/20
Exelixis, Inc. Presents at 22nd BIO CEO & Investor Conference, Feb-11-2020 02:00 PM	11/02/20
Exelixis, Inc. Presents at Stifel 2019 Healthcare Conference, Nov-19-2019 09:10 AM	19/11/19

Empresas relacionadas

Empresas cotizadas	2
EXELIXIS, INC.	Health Technology
VERA THERAPEUTICS, INC.	Health Technology

Empresas privadas	4
Berlex Biosciences
Ciba-Geigy Corp.	Health Technology
XWPharma Ltd. XWPharma Ltd. Pharmaceuticals: MajorHealth Technology Xwpharma operates as a biopharmaceutical company. It focuses on eveloping a portfolio of internally discovered product candidates for the treatment of neurological disorders. The company was founded by Jia-Ning Xiang and is headquartered in Wuhan, China.	Health Technology
CERo Therapeutics, Inc. CERo Therapeutics, Inc. BiotechnologyHealth Technology CERo Therapeutics, Inc. operates as a biopharmaceutical company. It offers cell-based therapies that incorporate multiple forms of tumor clearance into single cells. The company was founded by Daniel Mark Corey and Lawrence Corey and is headquartered in South San Francisco, CA.	Health Technology

Ver las conexiones de la empresa

Formación de Michael Morrissey.

Harvard University	Doctorate Degree
University of Wisconsin	Undergraduate Degree